Cargando…
Targeting the Interleukin-23/Interleukin-17 Inflammatory Pathway: Successes and Failures in the Treatment of Axial Spondyloarthritis
The IL-23/IL-17 pathway has been implicated in the etiopathogenesis of axial spondyloarthritis through studies of genetic polymorphisms associated with disease, an animal model with over-expression of IL-23 that resembles human disease, and observations that cytokines in this pathway can be found at...
Autores principales: | Wang, Runsheng, Maksymowych, Walter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446672/ https://www.ncbi.nlm.nih.gov/pubmed/34539646 http://dx.doi.org/10.3389/fimmu.2021.715510 |
Ejemplares similares
-
Biomarkers for Diagnosis of Axial Spondyloarthritis, Disease Activity, Prognosis, and Prediction of Response to Therapy
por: Maksymowych, Walter P.
Publicado: (2019) -
Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile
por: Queiro, Rubén, et al.
Publicado: (2023) -
The Initiation, but Not the Persistence, of Experimental Spondyloarthritis Is Dependent on Interleukin-23 Signaling
por: van Tok, Melissa N., et al.
Publicado: (2018) -
Clinical Trials Supporting the Role of the IL-17/IL-23 Axis in Axial Spondyloarthritis
por: Ceribelli, Angela, et al.
Publicado: (2021) -
No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
por: Zhang, Hua, et al.
Publicado: (2022)